OP40: Transcriptomic signature of response to vedolizumab in patients with moderate-to-severe ulcerative colitis: Results from an international, multicentre, retrospective cohort studyECCO'24 Stockholm
2024
SCI08: Charting Frontiers: European Insights into Global Trends in IBD EpidemiologyECCO'24 Stockholm
2024